Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brenda M. Sandmaier(University of Washington), Mohamed L. Sorror(University of Washington Medical Center), George E. Georges(Northwestern University), Marco Mielcarek(Fred Hutch Cancer Center), Mary E.D. Flowers(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David G. Maloney(Fred Hutch Cancer Center), Wolfgang Bethge(University of Tübingen), Firoozeh Sahebi(City Of Hope National Medical Center), Parameswaran Hari(Medical College of Wisconsin), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Amelia Langston(CancerCare Manitoba), Paul J. Martin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Boglarka Gyurkocza(Cornell University), Barry E. Storer(City Of Hope National Medical Center), Ginna G. Laport(Stanford Blood Center), Richard T. Maziarz(Oregon Health & Science University), Kai Hübel(University Hospital Cologne), Andrew M. Yeager(University of Arizona), Peter A. McSweeney(Colorado Blood Cancer Institute), Lars L. Vindeløv(University of Copenhagen), Finn Bo Petersen(Intermountain Healthcare), Edward Agura(Baylor University), Karl G. Blume(City Of Hope National Medical Center), Georg‐Nikolaus Franke(University Hospital Leipzig), Michael A. Pulsipher(Primary Children's Hospital), Michael B. Maris(Colorado Blood Cancer Institute), H. Joachim Deeg(Fred Hutch Cancer Center)
Cited by 212
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k